Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Precision and Personalized Medicine in Pharma - Thematic Intelligence" report has been added to ResearchAndMarkets.com's offering.
This report consolidates thinking and forecasts around how the healthcare, macroeconomic, technology, and regulatory trends will impact the precision and personalized medicine space, as well as providing insights into the leading players and future disruptors across the value chain, and providing insights into key drugs and markets
The monumental revolution in healthcare, driven by precision and personalized medicine, is profoundly transforming disease treatment and healthcare provision. The pursuit of enhanced patient outcomes, elevated quality of life, efficient disease management, and the transition from reactive to proactive care has stimulated a surge of investment into R&D within this niche.
Inspired by the digitalization of the healthcare sector, this market research report gives insights into the energetic evolution of diagnostics and therapeutics specifically developed for precision and personalized medicine. Innovation empowered by biomarker testing with next-generation sequencing (NGS), the advancement of artificial intelligence (AI) in data analytics for trend identification, and the application of Industry 4.0 technologies has amplified the quality and efficiency of complex drug production.
Tackling the greatest challenge of drug pricing and reimbursement will be a cornerstone to facilitating precision and personalized medicine. This report offers an in-depth study of the leaders in this field and the future game-changers across the value chains while providing insight into the crucial drugs and markets. Discover how the elements of healthcare, macroeconomics, technology, and regulation trends can impact your engagement with precision and personalized medicine.
Strategists, competitive intelligence professionals, and stakeholder in the pharmaceutical industry will find this report invaluable in identifying opportunities and also in discerning potential risks associated with precision and personalized medicine. It is a compass pointing to the future of personalized health care.
Precision and personalized medicine has already begun to reshape disease treatment paradigms and the provision of healthcare. Improved patient outcomes, increased quality of life, reduced financial and time expenditure of disease management with curative therapies, and a shift from reactive to proactive care are all driving investment in R&D in this space.
Scope
- A focused chapter on the key healthcare, technology, macroeconomic, and regulatory trends impacting precision and personalized medicine, and a review of the ways in which these trends will accelerate or hinder precision and personalized medicine.
- Industry analysis and market forecast for different therapies within precision and personalized medicine up to 2029.
- Case studies providing in-depth insight into some of the most recent and most influential developments in precision and personalized medicine, from recently approved gene therapies to new AI platforms to accelerate the development of new personalized drugs.
- Review of leaders and disruptors across the precision and personalized medicine value chain, covering diagnostics, therapeutics, and services.
- Thematic scorecard for drug development ranking companies on their investment in the top ten themes impacting the industry, one of which being precision and personalized medicine.
Reasons to Buy
- Understand the key trends accelerating or hindering the precision and personalized medicine space.
- See market forecasts for different therapies within precision and personalized medicine up to 2029.
- Understand recent and influential developments in precision and personalized medicine.
- Review of leaders and disruptors across the precision and personalized medicine value chain.
A selection of companies mentioned in this report includes
- Roche
- Illumina
- Agilent Technologies
- Abbott
- Myriad Genetics
- Thermo Fisher Scientific
- Guardant Health
- Tempus Labs
- Ocean Genomics
- Nicheri Biosciences
- Certis Oncology Solutions
- Novartis
- Merck & Co
- Johnson & Johnson
- Moderna
- Gilead Sciences
- CRISPR Therapeutics
- Bristol Myers Squibb
- Roche
- Sarepta Therapeutics
- Alaunos Therapeutics
- BrainStorm Cell Therapeutics
- OncoSec Medical
- Rocket Pharmaceuticals
- Vor Biopharma
- IQVIA
- Charles River Laboratories
- Lonza
- WuXi AppTec
- Syneos Health
- AmerisourceBergen
- Catalent
- Parexel
- CellCarta
- Multiply Lab
- Almac Group
- Kelsius
- Alynlyam Pharmaceutical
- Legend Biotech
- Gamida Cell
- Bio4t2
- Akkure Genomics
- Deep6 AI
- MatchMiner
- Dassault Systemes
- Alcaris Theranostics
- Quinten Health
- Qiagen
- PharmaLogic
- Perspective Therapeutics
- NH TherAguix
- Clarity Pharmaceuticals
- Cytiva
- Multiply Labs
- Takeda
- CSL Behring
- AstraZeneca
- Brainvectis
- Bluebird Bio
- Intellia Therapeutics
- Regeneron
- Mesoblast
- Replimune
- Verve Therapeutics
- Quell Therapeutics
- Genethon
- Hansa Biopharma
- SonoThera
- Arsenal Bioscience
- Tempus
- Elevate Bio
- Personalis
- CARsgen Therapeutics
- Amgen
- Ideaya Biosciences
- Vertex Pharmaceuticals
- Immatics
- Myeloid Therapeutics
- Prime Medicine
- Bayer
- Mammoth Biosciences
- Kate Therapeutics
- Mozart Therapeutics
- Acepodia
- ReNAgade Therapeutics
- Ray Therapeutics
- Convergent Therapeutics
- ImmuneBridge
- TORL BioTherapeutics
- CARGO Therapeutics
- Chroma Medicine
- Resalis Therapeutics
- IASO Biotherapeutics
- Metagenomi
- CG Oncology
- Tessa Therapeutics
- Engimmue Therapeutics
- Swedish Orphan Biovitrum
- Astellas Pharma
- Sartorius Stedim Biotech
- Viatris
- Catalent
- Galapagos
- ViaCyte
- Bora Pharmaceuticals
- UCB
- Krystal Biotech
- BioNTech
- Alphabet
- OpenAI
- C4XD
- Circulogene
- 10xGenomics
- SomaLogic
- Benevolent AI
- Exscientia
- Allscripts
- Atara Biotherapeutics
- JCR Pharmaceuticals
- Orchard Therapeutics
- Longeveron
- Daiichi Sankyo
- Silence Therapeutics
- Arrowhead Pharmaceuticals
- Poseida Therapeutics
- Beam Therapeutics
- Stemirna Therapeutics
- GreenLight Biosciences
- NeoCura Bio-Medical Technology
- Ono Pharmaceutical
- TG Therapeutics
- Viridian Therapeutics
- Celldex Therapeutics
- Exilis
- Tango Therapeutics
- Oncolytics Biotech.
For more information about this report visit https://www.researchandmarkets.com/r/rx90pe
Source: GlobalData
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
